The tumor markers assessed were cancer antigen 19.9(CA 19.9), 16.6 U/mL (normal 0 to 37) and carcinoembryonic antigen (CEA), 1.69 U/mL (normal 0 to 30). This evidence concerns the gene CEACAM5 and neoplasm.